Launching Biosimilars in Emerging Markets
In the lead up to the forthcoming “Biosimilars Commercialisation Summit” happening in May 2019, Pharma IQ had the opportunity to interview industry experts:
- Jose Carlos Ferreyra, President at Mexican Pharmaceutical Institute
- Fabiola Santillan, Country Manager at TTY Biopharm
- Pankaj Chaudhari, Manager - Global Regulatory Affairs (Biosimilars) at IQVIA
They shared their thoughts on the key factors to take into account when launching in the South Asian and Latin American regions.
Download the full interviews to get insights on how to win in these markets.
Please note: That all fields marked with an asterisk (*) are required.